| Deler fremragende | 11,617,250 shares |
| Insideraktier | 102.563.537 shares |
| Total Insiders | 19 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Phio Pharmaceuticals Corp. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Advanced RNA Technologies, LLC - | 1.221.723 | 1.221.723 | |
| Patricia A Bradford Director - [D] | 45.651 | 45.651 | |
| John A Barrett Chief Development Officer - [O] | 222.991 | 8.802 | |
| Robert J Bitterman Chairman, Pres. & CEO, Director - [D] [O] | 411.421 | 411.421 | |
| Keith L Brownlie Director - [D] | 20.000 | 789 | |
| Geert Cauwenbergh Director - [D] | 4.235 | 471 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Lisa Cabott Carson Chief Financial Officer - [O] | 94.000 | 94.000 | |
| David H Deming Director - [D] | 37.800 | 37.800 | |
| Gerrit Dispersyn President & CEO, Director - [D] [O] | 212.327 | 20.222 | |
| Dorman H. Paul Director - [D] | 20.370 | 1.940 | |
| Alexey Eliseev Chief Business Officer - [O] | 950.312 | 950.312 | |
| Robert L Ferrara Director - [D] | 38.766 | 38.766 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Jonathan E Freeman Director - [D] | 32.655 | 32.655 | |
|
Galena Biopharma, Inc.
10% Owner -
|
32.393.095 | 32.393.095 | |
| Infarinato Robert M. VP, CFO - [O] | 11.000 | 11.000 | |
| Caitlin Kontulis Secretary & VP Finance & Admin - [O] | 10.643 | 1.183 | |
| Curtis Lockshin Director - [D] | 35.155 | 35.155 | |
|
Opko Health, Inc.
10% Owner -
|
67.241.380 | 67.241.380 | |
| Pamela Pavco Chief Development Officer - [O] | 17.173 | 17.173 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i PHIO / Phio Pharmaceuticals Corp.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i PHIO / Phio Pharmaceuticals Corp.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-06 | 2026-02-05 | 4 | Freeman Jonathan E | PHIO | Common Stock, $.0001 par value | D | 16.600 | 32.655 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | Lockshin Curtis | PHIO | Common Stock, $.0001 par value | D | 16.600 | 35.155 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | Carson Lisa Cabott | PHIO | Common Stock, $.0001 par value | D | 47.000 | 94.000 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | Deming David H | PHIO | Common Stock, $.0001 par value | D | 23.800 | 37.800 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | BRADFORD PATRICIA A | PHIO | Common Stock, $.0001 par value | D | 18.500 | 45.651 | ||||||
| 2026-02-06 | 2026-02-05 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 120.000 | 411.421 | ||||||
| 2026-01-02 | 2025-12-31 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 1,0300 | 5.000 | 5 | 291.421 | ||||
| 2025-12-29 | 2025-12-23 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 1,0200 | 5.000 | 5 | 286.421 | ||||
| 2025-11-24 | 2025-11-21 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 1,1400 | 5.000 | 6 | 281.421 | ||||
| 2025-11-19 | 2025-11-18 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 1,2700 | 5.000 | 6 | 276.421 | ||||
| 2025-09-15 | 2025-09-11 | 4/A | Ferrara Robert L | PHIO | Common Stock, $.0001 par value | D | 23.100 | 38.766 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Deming David H | PHIO | Common Stock, $.0001 par value | D | 14.000 | 14.000 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Ferrara Robert L | PHIO | Common Stock, $.0001 par value | D | 23.000 | 38.666 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Freeman Jonathan E | PHIO | Common Stock, $.0001 par value | D | 14.700 | 16.055 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Lockshin Curtis | PHIO | Common Stock, $.0001 par value | D | 16.200 | 18.555 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | BRADFORD PATRICIA A | PHIO | Common Stock, $.0001 par value | D | 18.800 | 27.151 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Carson Lisa Cabott | PHIO | Common Stock, $.0001 par value | D | 47.000 | 47.000 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 250.000 | 271.421 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 2,3200 | -4.111 | -10 | 21.421 | ||||
| 2025-06-11 | 2025-06-10 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 2,4199 | 2.500 | 6 | 15.666 | ||||
| 2025-06-11 | 2025-06-10 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 2,4200 | 2.000 | 5 | 27.149 | ||||
| 2025-06-10 | 2025-06-09 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 2,7500 | 1.500 | 4 | 25.149 | ||||
| 2025-05-23 | 2025-05-22 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 1,7799 | 1.200 | 2 | 23.649 | ||||
| 2025-05-23 | 2025-05-21 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 1,7700 | 3.000 | 5 | 22.449 | ||||
| 2025-05-21 | 2025-05-20 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 1,8200 | 2.500 | 5 | 13.166 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 15.500 | 17.832 | ||||||
| 2024-09-13 | 2024-09-11 | 4 | Freeman Jonathan E | PHIO | Common Stock, $0.0001 par value | D | 1.000 | 1.000 | ||||||
| 2024-09-13 | 2024-09-11 | 4 | Infarinato Robert M. | PHIO | Common Stock, $0.0001 Par Value | D | 3.000 | 11.000 | ||||||
| 2024-09-12 | 2024-09-11 | 4 | Lockshin Curtis | PHIO | Common Stock, $0.0001 par value | D | 2.000 | 2.000 | ||||||
| 2024-09-12 | 2024-09-11 | 4 | BRADFORD PATRICIA A | PHIO | Common Stock, $0.0001 par value | D | 8.000 | 8.000 | ||||||
| 2024-09-12 | 2024-09-11 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 10.000 | 10.000 | ||||||
| 2024-08-15 | 2024-08-13 | 4 | Infarinato Robert M. | PHIO | Common stock, $0.0001 par value | D | 8.000 | 8.000 | ||||||
| 2024-06-11 | 2024-06-07 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,7400 | 1.000 | 1 | 20.990 | ||||
| 2024-06-10 | 2024-06-06 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,7500 | 1.000 | 1 | 19.990 | ||||
| 2024-03-05 | 2024-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,9580 | -335 | -0 | 10.643 | ||||
| 2024-02-27 | 2024-02-26 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,9100 | 2.500 | 2 | 18.990 | ||||
| 2024-02-22 | 2024-02-20 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,7600 | -1.804 | -1 | 16.490 | ||||
| 2024-02-20 | 2024-02-17 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,6600 | -523 | -0 | 10.978 | ||||
| 2024-02-20 | 2024-02-15 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,6500 | -658 | -0 | 11.501 | ||||
| 2023-10-03 | 2023-10-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 1,5100 | -917 | -1 | 18.294 | ||||
| 2023-07-05 | 2023-07-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 2,8400 | 1.000 | 3 | 19.211 | ||||
| 2023-07-05 | 2023-06-30 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 2,8800 | 1.000 | 3 | 18.211 | ||||
| 2023-06-15 | 2023-06-14 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 3,1000 | 2.000 | 6 | 6.000 | ||||
| 2023-03-03 | 2023-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 5,4900 | -335 | -2 | 12.159 | ||||
| 2023-02-22 | 2023-02-17 | 4 | Lockshin Curtis | PHIO | Common stock, $0.0001 par value | D | 1.500 | 3.197 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | BRADFORD PATRICIA A | PHIO | Common stock, $0.0001 par value | D | 1.500 | 3.167 | ||||||
| 2023-02-22 | 2023-02-20 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 11.000 | 17.211 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 1.500 | 4.000 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 1.500 | 4.235 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 4.500 | 12.494 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | Freeman Jonathan E | PHIO | Common stock, $0.0001 par value | D | 1.500 | 3.197 | ||||||
| 2023-02-17 | 2023-02-15 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 5,2000 | -657 | -3 | 7.994 | ||||
| 2022-12-15 | 2022-12-14 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,3900 | 2.000 | 1 | 74.541 | ||||
| 2022-12-08 | 2022-12-07 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,3900 | 2.000 | 1 | 72.541 | ||||
| 2022-12-06 | 2022-12-05 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,4300 | 2.000 | 1 | 70.541 | ||||
| 2022-12-05 | 2022-12-02 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 0,4082 | 5.000 | 2 | 30.000 | ||||
| 2022-11-29 | 2022-11-29 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,4000 | 215 | 0 | 68.541 | ||||
| 2022-11-29 | 2022-11-25 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,4200 | 2.500 | 1 | 68.326 | ||||
| 2022-11-28 | 2022-11-23 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 0,4099 | 2.000 | 1 | 25.000 | ||||
| 2022-11-16 | 2022-11-16 | 4 | Bitterman Robert J | PHIO | Series D Preferred Stock, $0.0001 par value | D | 1.750,0000 | 1 | 2 | 1 | ||||
| 2022-10-03 | 2022-10-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 40.000 | 65.826 | ||||||
| 2022-09-26 | 2022-08-09 | 4 | BRADFORD PATRICIA A | PHIO | Common stock, $0.0001 par value | D | 20.000 | 20.000 | ||||||
| 2022-03-03 | 2022-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,8210 | -4.011 | -3 | 103.815 | ||||
| 2022-03-03 | 2022-03-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 0,8210 | -8.954 | -7 | 212.327 | ||||
| 2022-02-16 | 2022-02-15 | 4 | Lockshin Curtis | PHIO | Common stock, $0.0001 par value | D | 10.000 | 20.366 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 68.000 | 107.826 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Freeman Jonathan E | PHIO | Common stock, $0.0001 par value | D | 10.000 | 20.364 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 10.000 | 23.000 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Dorman H. Paul | PHIO | Common stock, $0.0001 par value | D | 10.000 | 20.370 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 126.000 | 221.281 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 10.000 | 32.822 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 10.000 | 25.826 | ||||||
| 2021-08-17 | 2021-08-16 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 1,6300 | 6.000 | 10 | 95.281 | ||||
| 2021-03-05 | 2021-03-04 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 2,5600 | 1.953 | 5 | 89.281 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 10.000 | 15.826 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Freeman Jonathan E | PHIO | Common stock, $0.0001 par value | D | 10.000 | 10.364 | ||||||
| 2021-03-03 | 2021-03-03 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 3,1500 | 682 | 2 | 13.000 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 10.000 | 12.318 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Lockshin Curtis | PHIO | Common stock, $0.0001 par value | D | 10.000 | 10.366 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 10.000 | 22.822 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Dorman H. Paul | PHIO | Common stock, $0.0001 par value | D | 10.000 | 10.370 | ||||||
| 2021-03-03 | 2021-03-03 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 3,0300 | 2.500 | 8 | 87.328 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 68.450 | 84.828 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 34.600 | 39.826 | ||||||
| 2020-08-19 | 2020-08-19 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 2,5000 | 2.000 | 5 | 16.377 | ||||
| 2020-03-03 | 2020-03-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 2,9300 | -673 | -2 | 14.628 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 237.500 | 24 | 279.030 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 350.000 | 35 | 827.817 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 300.000 | 30 | 320.440 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 127.500 | 13 | 127.500 | ||||
| 2019-11-20 | 2019-11-18 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 225.000 | 22 | 704.841 | ||||
| 2019-08-02 | 2019-08-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,4030 | -749 | -0 | 41.530 | ||||
| 2019-08-02 | 2019-08-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 0,4030 | -1.236 | -0 | 477.817 | ||||
| 2019-08-02 | 2019-08-01 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,4030 | -1.751 | -1 | 479.841 | ||||
| 2019-04-24 | 2019-04-22 | 4 | Barrett John A | PHIO | Common stock, $0.0001 par value | D | 222.991 | 222.991 | ||||||
| 2019-03-05 | 2019-03-01 | 4 | Dispersyn Gerrit | PHIO | Common Stock | D | 407.703 | 479.053 | ||||||
| 2019-03-01 | 2019-02-28 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3798 | 152.415 | 58 | 481.592 | ||||
| 2019-02-19 | 2019-02-15 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3634 | 22.279 | 8 | 329.177 | ||||
| 2019-02-15 | 2019-02-13 | 4 | Dorman H. Paul | PHIO | Common stock | D | 10.000 | 20.375 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Lockshin Curtis | PHIO | Common stock | D | 10.000 | 20.130 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Freeman Jonathan E | PHIO | Common stock | D | 10.000 | 20.000 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Dispersyn Gerrit | PHIO | Common stock | D | 55.000 | 71.350 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Kontulis Caitlin | PHIO | Common stock | D | 27.000 | 40.214 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Bitterman Robert J | PHIO | Common stock | D | 10.000 | 20.440 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Brownlie Keith L | PHIO | Common stock | D | 10.000 | 20.000 | ||||||
| 2019-02-04 | 2019-02-01 | 4 | CAUWENBERGH GEERT | PHIO | Common Stock, $0.0001 par value | D | 0,3771 | 21.470 | 8 | 306.898 | ||||
| 2019-01-22 | 2019-01-18 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3412 | 23.729 | 8 | 285.428 | ||||
| 2019-01-07 | 2019-01-04 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3499 | 23.139 | 8 | 261.699 | ||||
| 2018-12-26 | 2018-12-21 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,2950 | 27.445 | 8 | 238.560 | ||||
| 2018-12-10 | 2018-12-07 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3700 | 21.882 | 8 | 211.115 | ||||
| 2018-11-26 | 2018-11-23 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3121 | 25.941 | 8 | 189.233 | ||||
| 2018-11-13 | 2018-11-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4330 | 18.698 | 8 | 163.292 | ||||
| 2018-10-29 | 2018-10-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4372 | 18.519 | 8 | 144.594 | ||||
| 2018-10-15 | 2018-10-12 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4699 | 17.230 | 8 | 126.075 | ||||
| 2018-10-01 | 2018-09-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,1700 | 73.587 | 86 | 108.845 | ||||
| 2018-08-03 | 2018-08-01 | 4 | Dorman H. Paul | RXII | Common Stock | D | 10.000 | 10.375 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Freeman Jonathan E | RXII | Common Stock | D | 10.000 | 10.000 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Lockshin Curtis | RXII | Common Stock | D | 10.000 | 10.130 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 1,79 | 10.500 | 10.500 | |||||
| 2018-08-03 | 2018-08-01 | 4 | Kontulis Caitlin | RXII | Common Stock | D | 10.500 | 11.024 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Dispersyn Gerrit | RXII | Stock option (right to buy) | D | 1,79 | 16.000 | 16.000 | |||||
| 2018-08-03 | 2018-08-01 | 4 | Dispersyn Gerrit | RXII | Common Stock | D | 16.000 | 16.350 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 1,79 | 21.000 | 21.000 | |||||
| 2018-08-03 | 2018-08-01 | 4 | CAUWENBERGH GEERT | RXII | Common Stock | D | 21.000 | 35.258 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Bitterman Robert J | RXII | Common Stock | D | 10.000 | 10.440 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Brownlie Keith L | RXII | Common Stock | D | 10.000 | 10.000 | ||||||
| 2017-10-02 | 2017-10-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4500 | 7.100 | 3 | 142.583 | ||||
| 2017-10-02 | 2017-10-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4600 | 200 | 0 | 135.483 | ||||
| 2017-10-02 | 2017-10-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4400 | 2.700 | 1 | 135.283 | ||||
| 2017-09-07 | 2017-09-07 | 4 | Eliseev Alexey | RXII | Common stock, par value $0.0001 | D | 0,5283 | -58.712 | -31 | 950.312 | ||||
| 2017-09-07 | 2017-09-06 | 4 | Eliseev Alexey | RXII | Common stock, par value $0.0001 | D | 0,5365 | -91.907 | -49 | 1.009.024 | ||||
| 2017-09-07 | 2017-09-05 | 4 | Eliseev Alexey | RXII | Common stock, par value $0.0001 | D | 0,5571 | -26.181 | -15 | 1.100.931 | ||||
| 2017-09-01 | 2017-09-01 | 4 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 0,5682 | -23.200 | -13 | 1.127.112 | ||||
| 2017-08-24 | 2017-08-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,5600 | 739 | 0 | 132.583 | ||||
| 2017-08-24 | 2017-08-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,5500 | 4.361 | 2 | 131.844 | ||||
| 2017-08-24 | 2017-08-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,5450 | 4.900 | 3 | 127.483 | ||||
| 2017-06-26 | 2017-06-23 | 4 | Dispersyn Gerrit | RXII | Common stock, $0.0001 par value | D | 0,6200 | 3.500 | 2 | 3.500 | ||||
| 2017-06-22 | 2017-06-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6200 | 5.000 | 3 | 122.583 | ||||
| 2017-06-22 | 2017-06-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6300 | 5.000 | 3 | 117.583 | ||||
| 2017-06-09 | 2017-06-09 | 4 | Eliseev Alexey | RXII | Series C Convertible Preferred Stock, $0.0001 par value | D | -332.499 | 0 | ||||||
| 2017-06-09 | 2017-06-09 | 4 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 332.499 | 1.150.312 | ||||||
| 2017-06-07 | 2017-06-06 | 4 | Freeman Jonathan E | RXII | Stock option (right to buy) | D | 0,54 | 3.500 | 3.500 | |||||
| 2017-04-26 | 2017-04-24 | 4 | Dispersyn Gerrit | RXII | Stock option (right to buy) | D | 0,65 | 95.000 | 95.000 | |||||
| 2017-04-26 | 2017-04-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6480 | 10.000 | 6 | 112.583 | ||||
| 2017-03-20 | 2017-03-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7655 | 15 | 0 | 102.583 | ||||
| 2017-03-20 | 2017-03-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7651 | 665 | 1 | 102.568 | ||||
| 2017-03-20 | 2017-03-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7695 | 9.320 | 7 | 101.903 | ||||
| 2017-02-21 | 2017-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6950 | 2.917 | 2 | 92.583 | ||||
| 2017-02-21 | 2017-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6924 | 6.883 | 5 | 89.666 | ||||
| 2017-02-21 | 2017-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6915 | 200 | 0 | 82.783 | ||||
| 2017-02-08 | 2017-02-08 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6850 | 10.000 | 7 | 82.583 | ||||
| 2017-02-03 | 2017-02-01 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 0,63 | 13.000 | 13.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Pavco Pamela | RXII | Stock option (right to buy) | D | 0,63 | 7.000 | 7.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Bitterman Robert J | RXII | Stock option (right to buy) | D | 0,63 | 2.000 | 2.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Brownlie Keith L | RXII | Stock option (right to buy) | D | 0,63 | 2.000 | 2.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Lockshin Curtis | RXII | Stock option (right to buy) | D | 0,63 | 2.000 | 2.000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 0,63 | 2.500 | 2.500 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Dorman H. Paul | RXII | Stock option (right to buy) | D | 0,63 | 2.000 | 2.000 | |||||
| 2017-01-26 | 2017-01-25 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6968 | 9.700 | 7 | 72.583 | ||||
| 2017-01-26 | 2017-01-25 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6900 | 300 | 0 | 62.883 | ||||
| 2017-01-19 | 2017-01-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6949 | 600 | 0 | 62.583 | ||||
| 2017-01-19 | 2017-01-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6946 | 3.000 | 2 | 61.983 | ||||
| 2017-01-19 | 2017-01-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6950 | 6.400 | 4 | 58.983 | ||||
| 2017-01-17 | 3 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 1.635.626 | ||||||||
| 2017-01-17 | 3 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 1.635.626 | ||||||||
| 2017-01-03 | 2016-12-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7260 | 2.000 | 1 | 52.583 | ||||
| 2016-12-27 | 2016-12-23 | 4 | CAUWENBERGH GEERT By spouse | RXII | Common stock, $0.0001 par value | I | 0,7190 | 3.000 | 2 | 4.500 | ||||
| 2016-12-23 | 2016-12-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7490 | 3.000 | 2 | 53.583 | ||||
| 2016-12-20 | 2016-12-16 | 4 | Pavco Pamela | RXII | Common stock warrant | D | 0,90 | 11.111 | 11.111 | |||||
| 2016-12-20 | 2016-12-16 | 4 | Pavco Pamela | RXII | Common stock, $0.0001 par value | D | 0,9000 | 11.111 | 10 | 17.173 | ||||
| 2016-12-20 | 2016-12-16 | 4 | CAUWENBERGH GEERT | RXII | Common stock warrant | D | 0,90 | 33.333 | 33.333 | |||||
| 2016-12-20 | 2016-12-16 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,9000 | 33.333 | 30 | 50.583 | ||||
| 2016-02-12 | 2016-02-10 | 4 | Pavco Pamela | RXII | Stock option (right to buy) | D | 0,29 | 66.000 | 66.000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 0,29 | 133.000 | 133.000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Bitterman Robert J | RXII | Stock option (right to buy) | D | 0,29 | 16.666 | 16.666 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Brownlie Keith L | RXII | Stock option (right to buy) | D | 0,29 | 16.666 | 16.666 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Lockshin Curtis | RXII | Stock option (right to buy) | D | 0,29 | 16.666 | 16.666 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 0,29 | 20.000 | 20.000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Dorman H. Paul | RXII | Stock option (right to buy) | D | 0,29 | 16.666 | 16.666 | |||||
| 2015-06-23 | 2015-06-22 | 4 | CAUWENBERGH GEERT | RXII | Overallotment purchase right | D | 0,46 | -35.000 | 0 | |||||
| 2015-06-23 | 2015-06-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4550 | 35.000 | 16 | 172.500 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Bitterman Robert J | RXII | Overallotment purchase rights | D | 0,46 | 18.750 | 18.750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Bitterman Robert J | RXII | Common stock warrants | D | 0,52 | 18.750 | 18.750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 0,4000 | 37.500 | 15 | 44.000 | ||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT By spouse | RXII | Overallotment purchase right | I | 0,46 | 5.000 | 5.000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT By spouse | RXII | Common stock warrant | I | 0,52 | 5.000 | 5.000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock warrant | D | 0,52 | 35.000 | 35.000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT | RXII | Overallotment purchase right | D | 0,46 | 35.000 | 35.000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT By spouse | RXII | Common stock, $0.0001 par value | I | 0,4000 | 10.000 | 4 | 15.000 | ||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4000 | 70.000 | 28 | 137.500 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Lockshin Curtis | RXII | Overallotment purchase right | D | 0,46 | 6.000 | 6.000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Lockshin Curtis | RXII | Common stock warrant | D | 0,52 | 6.000 | 6.000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Lockshin Curtis | RXII | Common stock, $0.0001 par value | D | 0,4000 | 12.000 | 5 | 13.000 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Pavco Pamela | RXII | Common stock purchase warrant | D | 0,52 | 6.250 | 6.250 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Pavco Pamela | RXII | Overallotment purchase right | D | 0,46 | 6.250 | 6.250 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Pavco Pamela | RXII | Common stock, $0.0001 par value | D | 0,4000 | 12.500 | 5 | 33.718 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Dorman H. Paul | RXII | Overallotment purchase right | D | 0,46 | 18.750 | 18.750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Dorman H. Paul | RXII | Common stock warrant | D | 0,52 | 18.750 | 18.750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Dorman H. Paul | RXII | Common stock, $0.0001 par value | D | 0,4000 | 37.500 | 15 | 37.500 | ||||
| 2015-06-02 | 2015-06-01 | 4 | Pavco Pamela | RXII | Stock option (right to buy) | D | 0,38 | 66.000 | 66.000 | |||||
| 2015-06-02 | 2015-06-01 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 0,38 | 133.000 | 133.000 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Bitterman Robert J | RXII | Stock option (right to buy) | D | 0,38 | 16.666 | 16.666 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Brownlie Keith L | RXII | Stock option (right to buy) | D | 0,38 | 16.666 | 16.666 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Lockshin Curtis | RXII | Stock option (right to buy) | D | 0,38 | 16.666 | 16.666 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 0,38 | 10.000 | 10.000 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Dorman H. Paul | RXII | Stock option (right to buy) | D | 0,38 | 16.666 | 16.666 | |||||
| 2015-04-02 | 2015-04-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7192 | 5.000 | 4 | 67.500 | ||||
| 2015-02-18 | 2015-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,1700 | 4.000 | 5 | 62.500 | ||||
| 2015-02-11 | 2015-02-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,2499 | 1.156 | 1 | 58.500 | ||||
| 2015-02-11 | 2015-02-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,2400 | 644 | 1 | 57.344 | ||||
| 2015-02-11 | 2015-02-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,2200 | 200 | 0 | 56.700 | ||||
| 2015-01-23 | 2015-01-22 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 1,1900 | 1.853 | 2 | 6.500 | ||||
| 2015-01-23 | 2015-01-22 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 1,2000 | 3.147 | 4 | 4.647 | ||||
| 2015-01-20 | 2015-01-20 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,0300 | 10.000 | 10 | 56.500 | ||||
| 2014-12-31 | 2014-12-30 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 1,5893 | 500 | 1 | 46.500 | ||||
| 2014-12-31 | 2014-12-30 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 1,5867 | 2.000 | 3 | 46.000 | ||||
| 2014-10-14 | 2014-10-13 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,6799 | 3.000 | 5 | 44.000 | ||||
| 2014-09-23 | 2014-09-19 | 4 | CAUWENBERGH GEERT By child | RXII | Common stock, $0.0001 | I | 2,2000 | 4.500 | 10 | 4.500 | ||||
| 2014-09-16 | 2014-09-16 | 4 | CAUWENBERGH GEERT By Spouse | RXII | Common stock, $0.0001 par value | I | 2,0780 | 5.000 | 10 | 46.000 | ||||
| 2014-09-15 | 2014-09-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,1900 | 2.000 | 4 | 41.000 | ||||
| 2014-09-15 | 2014-09-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,1899 | 3.000 | 7 | 39.000 | ||||
| 2014-09-15 | 2014-09-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,1799 | 5.000 | 11 | 36.000 | ||||
| 2014-08-04 | 2014-07-31 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 2,4800 | 400 | 1 | 1.221.723 | ||||
| 2014-07-17 | 2014-07-15 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 2,5000 | 1.000 | 2 | 31.000 | ||||
| 2014-07-09 | 2014-07-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,5699 | 1.400 | 4 | 30.000 | ||||
| 2014-07-02 | 2014-07-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,8600 | 300 | 1 | 28.600 | ||||
| 2014-07-02 | 2014-07-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,8599 | 1.000 | 3 | 28.300 | ||||
| 2014-07-02 | 2014-07-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,8500 | 700 | 2 | 27.300 | ||||
| 2014-06-26 | 2014-06-25 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0100 | 500 | 2 | 26.600 | ||||
| 2014-06-19 | 2014-06-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9600 | 800 | 2 | 26.100 | ||||
| 2014-06-19 | 2014-06-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0000 | 200 | 1 | 25.300 | ||||
| 2014-06-19 | 2014-06-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9921 | 1.000 | 3 | 25.100 | ||||
| 2014-06-09 | 2014-06-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0499 | 800 | 2 | 24.100 | ||||
| 2014-06-09 | 2014-06-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0500 | 200 | 1 | 23.300 | ||||
| 2014-06-05 | 2014-06-04 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9715 | 1.000 | 3 | 23.100 | ||||
| 2014-06-05 | 2014-06-04 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9140 | 1.000 | 3 | 22.100 | ||||
| 2014-06-04 | 2014-06-02 | 4 | Bitterman Robert J | RXII | Stock Option (right to buy) | D | 2,85 | 16.666 | 16.666 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Brownlie Keith L | RXII | Stock Option (right to buy) | D | 2,85 | 16.666 | 16.666 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Lockshin Curtis | RXII | Stock Option (right to buy) | D | 2,85 | 16.666 | 16.666 | |||||
| 2014-06-04 | 2014-06-02 | 4 | CAUWENBERGH GEERT | RXII | Stock Option (right to buy) | D | 2,85 | 133.000 | 133.000 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Pavco Pamela | RXII | Stock Option (right to buy) | D | 2,85 | 66.000 | 66.000 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Kontulis Caitlin | RXII | Stock Option (right to buy) | D | 2,85 | 10.000 | 10.000 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Dorman H. Paul | RXII | Stock Option (right to buy) | D | 2,85 | 16.666 | 16.666 | |||||
| 2014-05-15 | 2014-04-22 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,1100 | -5.000 | -21 | 1.250.315 | ||||
| 2014-03-26 | 2014-03-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0000 | -2.000 | -12 | 1.255.315 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,5500 | -1.941 | -11 | 1.257.315 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,7000 | -1.000 | -6 | 1.259.256 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,6100 | -1.000 | -6 | 1.260.256 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,5500 | -59 | -0 | 1.261.256 | ||||
| 2014-03-26 | 2014-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | -1.400 | -9 | 1.261.315 | ||||
| 2014-03-26 | 2014-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | -500 | -3 | 1.262.715 | ||||
| 2014-03-26 | 2014-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1100 | -100 | -1 | 1.263.215 | ||||
| 2014-03-26 | 2014-03-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0000 | -2.000 | -12 | 1.263.315 | ||||
| 2014-03-21 | 2014-02-28 | 4/A | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,2000 | -2.600 | -16 | 1.247.315 | ||||
| 2014-03-21 | 2014-02-27 | 4/A | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | -400 | -2 | 1.276.915 | ||||
| 2014-03-11 | 2014-03-04 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,8000 | -2.000 | -12 | 1.265.315 | ||||
| 2014-03-11 | 2014-03-04 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,9100 | -2.000 | -12 | 1.267.315 | ||||
| 2014-03-11 | 2014-03-03 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1500 | -5.000 | -31 | 1.269.315 | ||||
| 2014-03-11 | 2014-02-28 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,2000 | 2.600 | 16 | 1.274.315 | ||||
| 2014-03-11 | 2014-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | 400 | 2 | 1.276.915 | ||||
| 2014-03-11 | 2014-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1100 | -1.300 | -8 | 1.277.315 | ||||
| 2014-03-11 | 2014-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,4500 | -5.000 | -32 | 1.278.615 | ||||
| 2014-03-11 | 2014-02-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0300 | -400 | -2 | 1.283.615 | ||||
| 2014-03-11 | 2014-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,5500 | -5.000 | -33 | 1.284.015 | ||||
| 2014-03-11 | 2014-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0000 | -5.000 | -30 | 1.289.015 | ||||
| 2014-03-06 | 2014-02-24 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,3000 | -1.575 | -10 | 1.266.585 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,0000 | -5.000 | -25 | 1.268.160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,8500 | -5.000 | -24 | 1.273.160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,1500 | -5.000 | -26 | 1.278.160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,8000 | -576 | -3 | 1.283.160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7100 | -2.100 | -10 | 1.283.736 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7350 | -2.900 | -14 | 1.285.836 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7500 | -5.641 | -27 | 1.288.736 | ||||
| 2014-03-06 | 2014-02-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7000 | -1.200 | -6 | 1.294.377 | ||||
| 2013-11-01 | 2013-10-31 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,1900 | 800 | 3 | 21.100 | ||||
| 2013-11-01 | 2013-10-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0900 | 200 | 1 | 20.300 | ||||
| 2013-10-24 | 2013-10-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3400 | 1.000 | 3 | 20.100 | ||||
| 2013-10-22 | 2013-10-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4300 | 300 | 1 | 19.100 | ||||
| 2013-10-22 | 2013-10-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5000 | 200 | 1 | 18.800 | ||||
| 2013-10-22 | 2013-10-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3800 | 100 | 0 | 18.600 | ||||
| 2013-10-22 | 2013-10-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,2900 | 100 | 0 | 18.500 | ||||
| 2013-10-16 | 2013-10-16 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5300 | 100 | 0 | 18.400 | ||||
| 2013-10-16 | 2013-10-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5100 | 100 | 0 | 18.300 | ||||
| 2013-10-16 | 2013-10-14 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5400 | 100 | 0 | 18.200 | ||||
| 2013-10-09 | 2013-10-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,1500 | 1.000 | 3 | 18.100 | ||||
| 2013-10-07 | 2013-10-04 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4900 | 200 | 1 | 17.100 | ||||
| 2013-10-07 | 2013-10-03 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5100 | 100 | 0 | 16.900 | ||||
| 2013-10-02 | 2013-09-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4200 | 300 | 1 | 16.800 | ||||
| 2013-09-26 | 2013-09-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5000 | 300 | 1 | 16.500 | ||||
| 2013-09-26 | 2013-09-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4900 | 100 | 0 | 16.200 | ||||
| 2013-09-24 | 2013-09-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4900 | 174 | 1 | 16.100 | ||||
| 2013-09-23 | 2013-09-20 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5200 | 326 | 1 | 15.926 | ||||
| 2013-09-19 | 2013-09-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4800 | 100 | 0 | 15.600 | ||||
| 2013-09-19 | 2013-09-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5000 | 100 | 0 | 15.500 | ||||
| 2013-09-17 | 2013-09-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 200 | 1 | 15.400 | ||||
| 2013-09-16 | 2013-09-13 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6000 | 100 | 0 | 15.200 | ||||
| 2013-09-16 | 2013-09-13 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 100 | 0 | 15.100 | ||||
| 2013-09-12 | 2013-09-11 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 150 | 1 | 15.000 | ||||
| 2013-09-12 | 2013-09-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5800 | 150 | 1 | 14.850 | ||||
| 2013-09-12 | 2013-09-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6500 | 200 | 1 | 14.700 | ||||
| 2013-09-03 | 2013-08-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3500 | 200 | 1 | 14.500 | ||||
| 2013-09-03 | 2013-08-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3800 | 100 | 0 | 14.300 | ||||
| 2013-08-30 | 2013-08-29 | 4 | Lockshin Curtis | RXII | Common stock, $0.0001 par value | D | 3,7000 | 1.000 | 4 | 1.000 | ||||
| 2013-08-30 | 2013-08-29 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 200 | 1 | 14.200 | ||||
| 2013-08-30 | 2013-08-29 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4000 | 200 | 1 | 14.000 | ||||
| 2013-08-29 | 2013-08-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7000 | 100 | 0 | 13.800 | ||||
| 2013-08-29 | 2013-08-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6000 | 100 | 0 | 13.700 | ||||
| 2013-08-29 | 2013-08-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7500 | 200 | 1 | 13.600 | ||||
| 2013-08-28 | 2013-08-27 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7000 | 100 | 0 | 13.400 | ||||
| 2013-08-27 | 2013-08-26 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 3,9000 | 500 | 2 | 1.500 | ||||
| 2013-08-26 | 2013-08-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6900 | 200 | 1 | 13.300 | ||||
| 2013-08-26 | 2013-08-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7500 | 100 | 0 | 13.100 | ||||
| 2013-08-23 | 2013-08-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6200 | 300 | 1 | 13.000 | ||||
| 2013-08-22 | 2013-08-21 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,8000 | 680 | 3 | 12.700 | ||||
| 2013-08-21 | 2013-08-20 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 3,7500 | 200 | 1 | 12.020 | ||||
| 2013-08-21 | 2013-08-20 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 3,7000 | 200 | 1 | 11.820 | ||||
| 2013-08-21 | 2013-08-20 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 3,9000 | 300 | 1 | 11.620 | ||||
| 2013-08-20 | 2013-08-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6500 | 100 | 0 | 11.320 | ||||
| 2013-08-20 | 2013-08-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6700 | 120 | 0 | 11.220 | ||||
| 2013-08-20 | 2013-08-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,8600 | 100 | 0 | 11.100 | ||||
| 2013-08-06 | 2013-08-06 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0500 | 350 | 1 | 11.000 | ||||
| 2013-08-06 | 2013-08-05 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0300 | 150 | 1 | 10.650 | ||||
| 2013-08-06 | 2013-08-05 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0000 | 500 | 2 | 10.500 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0500 | 100 | 0 | 1.000 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0200 | 100 | 0 | 900 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0100 | 100 | 0 | 800 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0500 | 200 | 1 | 700 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,1300 | 500 | 2 | 500 | ||||
| 2013-07-31 | 2013-07-31 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,1000 | 500 | 2 | 9.833 | ||||
| 2013-07-31 | 2013-07-31 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0200 | 167 | 1 | 10.000 | ||||
| 2013-07-31 | 2013-07-23 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1580 | -28.000 | -4 | 38.820.446 | ||||
| 2013-07-30 | 2013-07-29 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,5400 | 500 | 2 | 9.333 | ||||
| 2013-07-29 | 2013-07-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,8700 | 500 | 2 | 8.833 | ||||
| 2013-07-22 | 2013-07-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1490 | -111.684 | -17 | 38.918.656 | ||||
| 2013-07-22 | 2013-07-18 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1535 | -100.000 | -15 | 38.960.130 | ||||
| 2013-07-22 | 2013-07-18 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1525 | -100.000 | -15 | 39.060.130 | ||||
| 2013-07-22 | 2013-07-17 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | -100.000 | -16 | 39.160.130 | ||||
| 2013-07-15 | 2013-07-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | -95.000 | -19 | 39.260.130 | ||||
| 2013-07-15 | 2013-07-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1990 | -5.000 | -1 | 39.355.130 | ||||
| 2013-07-15 | 2013-07-10 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -100.000 | -20 | 39.360.130 | ||||
| 2013-07-15 | 2013-07-10 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -100.000 | -20 | 39.360.130 | ||||
| 2013-07-15 | 2013-07-10 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1960 | -30.000 | -6 | 39.560.130 | ||||
| 2013-07-08 | 2013-07-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -18.180 | -4 | 39.590.130 | ||||
| 2013-07-08 | 2013-07-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1940 | -100.000 | -19 | 39.608.310 | ||||
| 2013-07-08 | 2013-07-03 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1945 | -50.000 | -10 | 39.708.310 | ||||
| 2013-07-08 | 2013-07-03 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | -50.000 | -10 | 39.758.310 | ||||
| 2013-07-03 | 2013-07-02 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | -30.000 | -6 | 39.808.310 | ||||
| 2013-07-03 | 2013-07-02 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1970 | -9.249 | -2 | 39.838.310 | ||||
| 2013-07-03 | 2013-07-01 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1970 | -50.000 | -10 | 39.847.559 | ||||
| 2013-07-03 | 2013-07-01 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1965 | -50.000 | -10 | 39.897.559 | ||||
| 2013-07-02 | 2013-06-28 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | -46.874 | -9 | 39.947.559 | ||||
| 2013-07-02 | 2013-06-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | -45.000 | -9 | 39.994.433 | ||||
| 2013-07-02 | 2013-06-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | -60.000 | -12 | 40.039.433 | ||||
| 2013-07-02 | 2013-06-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | -50.000 | -10 | 40.099.433 | ||||
| 2013-07-02 | 2013-06-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | -25.500 | -5 | 40.149.433 | ||||
| 2013-07-02 | 2013-06-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -50.000 | -10 | 40.174.933 | ||||
| 2013-07-02 | 2013-06-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1940 | -50.000 | -10 | 40.224.933 | ||||
| 2013-06-11 | 2013-06-07 | 4 | CAUWENBERGH GEERT | RXII | Stock Option (right to buy) | D | 0,20 | 4.000.000 | 4.000.000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Pavco Pamela | RXII | Stock Option (right to buy) | D | 0,20 | 2.000.000 | 2.000.000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Bitterman Robert J | RXII | Stock Option (right to buy) | D | 0,20 | 500.000 | 500.000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Brownlie Keith L | RXII | Stock Option (right to buy) | D | 0,20 | 500.000 | 500.000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Kontulis Caitlin | RXII | Stock Option (right to buy) | D | 0,20 | 300.000 | 300.000 | |||||
| 2013-05-03 | 2013-04-18 | 4/A | Lockshin Curtis | RXII | Stock Option (right to buy) | D | 0,24 | 1.000.000 | 1.000.000 | |||||
| 2013-05-03 | 2013-04-18 | 4/A | Dorman H. Paul | RXII | Stock Option (right to buy) | D | 0,24 | 1.000.000 | 1.000.000 | |||||
| 2013-05-02 | 2013-05-02 | 4 | Galena Biopharma, Inc. | RXII | Common Stock, $0.0001 par value | D | 0,1905 | -253.000 | -48 | 32.393.095 | ||||
| 2013-05-02 | 2013-05-01 | 4 | Galena Biopharma, Inc. | RXII | Common Stock, $0.0001 par value | D | 0,1925 | -659.500 | -127 | 32.646.095 | ||||
| 2013-05-02 | 2013-04-30 | 4 | Galena Biopharma, Inc. | RXII | Common Stock, $0.0001 par value | D | 0,2138 | -171.000 | -37 | 33.305.595 | ||||
| 2013-04-23 | 2013-03-18 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3480 | -52.900 | -18 | 39.831.365 | ||||
| 2013-04-23 | 2013-03-15 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3250 | -100.000 | -32 | 39.884.265 | ||||
| 2013-04-23 | 2013-03-14 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3310 | -126.843 | -42 | 39.984.265 | ||||
| 2013-04-23 | 2013-03-14 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3340 | -7.500 | -3 | 40.111.108 | ||||
| 2013-04-23 | 2013-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2720 | -100.000 | -27 | 40.118.608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2730 | -100.000 | -27 | 40.218.608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2210 | -100.000 | -22 | 40.318.608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2400 | -100.000 | -24 | 40.418.608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2330 | -100.000 | -23 | 40.518.608 | ||||
| 2013-04-23 | 2013-03-08 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1940 | -50.000 | -10 | 40.618.608 | ||||
| 2013-04-23 | 2013-03-07 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | -50.000 | -10 | 40.668.608 | ||||
| 2013-04-23 | 2013-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1490 | -36.570 | -5 | 40.718.608 | ||||
| 2013-04-23 | 2013-03-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1450 | -30.000 | -4 | 40.755.178 | ||||
| 2013-04-23 | 2013-03-04 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 | D | 0,1450 | -50.000 | -7 | 40.785.178 | ||||
| 2013-04-23 | 2013-03-01 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 | D | 0,1500 | -20.000 | -3 | 40.835.178 | ||||
| 2013-04-23 | 2013-02-28 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | -200 | -0 | 40.855.178 | ||||
| 2013-04-23 | 2013-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | -29.888 | -5 | 40.855.378 | ||||
| 2013-04-23 | 2013-02-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1750 | -4.000 | -1 | 40.885.266 | ||||
| 2013-04-23 | 2013-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1820 | -8.000 | -1 | 40.889.266 | ||||
| 2013-04-23 | 2013-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1800 | -92.000 | -17 | 40.897.266 | ||||
| 2013-04-23 | 2013-02-22 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | -40.000 | -6 | 40.989.266 | ||||
| 2013-04-23 | 2013-02-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1920 | -1.000 | -0 | 41.029.266 | ||||
| 2013-04-23 | 2013-02-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1900 | -49.000 | -9 | 41.030.266 | ||||
| 2013-04-23 | 2013-02-15 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1360 | -40.000 | -5 | 41.079.266 | ||||
| 2013-04-23 | 2013-02-14 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1160 | -30.000 | -3 | 41.119.266 | ||||
| 2013-04-23 | 2013-02-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0910 | -20.000 | -2 | 41.149.266 | ||||
| 2013-04-23 | 2013-02-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0950 | -20.000 | -2 | 41.169.266 | ||||
| 2013-04-23 | 2013-02-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1150 | -40.000 | -5 | 41.189.266 | ||||
| 2013-04-23 | 2013-02-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0860 | -20.000 | -2 | 41.229.266 | ||||
| 2013-04-23 | 2013-02-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0760 | -10.000 | -1 | 41.249.266 | ||||
| 2013-04-23 | 2013-03-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2320 | -48.500 | -11 | 39.684.265 | ||||
| 2013-04-23 | 2013-03-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2310 | -57.100 | -13 | 39.732.765 | ||||
| 2013-04-23 | 2013-03-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2550 | -1.500 | -0 | 39.789.865 | ||||
| 2013-04-23 | 2013-03-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3000 | -40.000 | -12 | 39.791.365 | ||||
| 2013-04-22 | 2013-04-18 | 4 | Lockshin Curtis | RXII | Stock Option (right to buy) | D | 0,24 | 1.000.000 | 1.000.000 | |||||
| 2013-04-22 | 2013-04-18 | 4 | Dorman H. Paul | RXII | Stock Option (right to buy) | D | 0,24 | 1.000.000 | 1.000.000 | |||||
| 2013-03-19 | 3 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 41.259.266 | ||||||||
| 2013-03-13 | 3 | Opko Health, Inc. | RXII | Common Stock | D | 67.241.380 | ||||||||
| 2013-03-08 | 2013-03-06 | 4 | CAUWENBERGH GEERT | RXII | Common Stock | D | 0,1450 | 250.000 | 36 | 250.000 | ||||
| 2013-03-01 | 3 | Pavco Pamela | RXII | Common stock, par value $0.0001 | D | 90.153 | ||||||||
| 2013-03-01 | 3 | Galena Biopharma, Inc. | RXII | Common stock, $0.0001 par value | D | 33.476.595 | ||||||||
| 2013-03-01 | 3 | Kontulis Caitlin | RXII | Common stock, par value $0.0001 | D | 2.231 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
